Drugs / S-1117
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06828393 | Mar 2025 → Mar 2026 overdue | — | Seismic Therapeutic AU Pty Ltd | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-1117 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06828393 ↗ |
| Route | Intravenous | “S-1117 via subcutaneous or intravenous administration.” NCT06828393 ↗ |
| Route | Subcutaneous | “S-1117 via subcutaneous or intravenous administration.” NCT06828393 ↗ |